Chinese Journal of Organic Chemistry ›› 2004, Vol. 24 ›› Issue (7): 783-787. Previous Articles     Next Articles

哌嗪取代卟啉的合成、表征及其抗癌活性

李和平*,a,b, 郭灿城c, 阮建明a, 黄伯云a   

  1. a中南大学粉末冶金国家重点实验室 长沙 410083
    b长沙电力学院化学系 长沙 410077
    c湖南大学化学化工学院 长沙 410082
  • 收稿日期:2003-06-23 修回日期:2003-11-25 接受日期:2004-02-09 发布日期:2022-09-20
  • 通讯作者: *E-mail: lihepinghn@sohu.com; Tel.: 0731-8876644
  • 基金资助:
    国家自然科学基金(No. 20142003)、湖南省教育厅青年基金(No. 02B022)资助项目

Synthesis, Characterization and Anticancer Activity of Piperazine Substituted Porphyrins

LI, He-Ping*,a,b, GUO, Can-Chengc, RUAN, Jian-Minga, HUANG, Bai-Yuna   

  1. a State Key Laboratory for Powder Metallurgy, Central South University, Changsha 410083
    b Department of Chemistry, Changsha University of Electric Power, Changsha 410077
    c College of Chemistry & Chemical Engineering, Hunan University, Changsha 410082
  • Received:2003-06-23 Revised:2003-11-25 Accepted:2004-02-09 Published:2022-09-20

A molecular design strategy was outlined for the synthesis of porphyrin-containing anticancer drugs. A series of six porphyrin monomers, 5,10,15,20-tetra[4-(4′-ethylpiperazinyl)phenyl]porphyrin (TEPPH2, 8a), 5,10,15,20-tetra[4-(4′-butylpiperazinyl)phenyl]porphyrin (TBPPH2, 8b), 5,10,15,20-tetra[4-(4′-heptylpiperazinyl)-phenyl]porphyrin (THPPH2, 8c), 5,10,15,20-tetra[4-(4′-phenylpiperazinyl)phenyl]porphyrin (TPhPPH2, 8d), 5-[4-(4′-ethylpiperazinyl)phenyl]-10,15,20-triphenylporphyrin (EPTPPH2, 8e) and 5-[4-(4′-butylpiperazinyl)-phenyl]-10,15,20-triphenylporphyrin (BPTPPH2, 8f), have been prepared by the direct condensation of substituted benzaldehydes with pyrrole. Each porphyrin bears one or four substituted piperazine moieties that have been used as drugs. Their structures were characterized by elemental analysis, MS, 1HNMR, IR and UV-vis spectra. The preliminary investigation of anticancer activity of these porphyrins showed that the porphyrins might have potential application in medicine owing to their special biological activity.

Key words: porphyrin, piperazine, synthesis, anticancer activity